DOZURIL 25 mg/ml oral solution for poultry

Main information

  • Trade name:
  • DOZURIL 25 mg/ml oral solution for poultry
  • Pharmaceutical form:
  • Oral solution
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • DOZURIL 25 mg/ml oral solution for poultry
    Romania
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • toltrazuril
  • Therapeutic area:
  • Chicken Broilers

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • FR/V/0233/001
  • Authorization date:
  • 25-04-2012
  • EU code:
  • FR/V/0233/001
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

SUMMARYOFPRODUCTCHARACTERISTICS

1.NAMEOFTHEVETERINARYMEDICINALPRODUCT

Dozuril25mg/mlsolutionforuseindrinkingwaterforchickens

2.QUALITATIVEANDQUANTITATIVECOMPOSITION

Each1mlcontains:

Activesubstance

Toltrazuril

25.0mg

Forafulllistofexcipients,seesection6.1

3.PHARMACEUTICALFORM

Solutionforuseindrinkingwater.

Clearcolourlesstobrownsolution

4.CLINICALPARTICULARS

4.1Targetspecies:

Chickens(pulletsandbreeders)

4.2Indicationsforuse,specifyingthetargetspecies

Treatmentofcoccidiosisinpulletsandbroilerbreeders.

4.3Contra-indications

None.

4.4Specialwarnings,foreachtargetspecies

Goodhygienecanreducetheriskofcoccidiosis.Itisthereforerecommendedthatany

deficienciesinhusbandryshouldbeaddressedinadditiontotreatment.Poultryhousesshould

bekeptcleananddry.

Itisrecommendedthatallindividualsinthegrouparetreated.

Forbestresults,treatmentshouldbeinitiatedbeforetheclinicalsignsofdiseasehavespread

throughoutthewholegroup.

4.5Specialprecautionsforuse

i)Specialprecautionsforuseinanimals

Aswithallanticoccidials,prolongedusemayresultinthedevelopmentofresistantstrains.

ii)Specialprecautionstobetakenbythepersonadministeringtheveterinarymedicinal

producttoanimals

Avoidskinandeyecontactwiththeproduct.

Wearpersonalprotectiveclothing,includingsyntheticrubbergloveswhenhandlingtheproduct.

Washanysplashesfromskinoreyesimmediatelywithwater.

Washhandsandanyexposedskinafteruse.

Donoteat,drinkorsmokewhilstusingtheproduct.

iii)Otherprecautions

None

4.6Adversereactions(frequencyandseriousness)

Notknown.

4.7Useduringpregnancyandlactationorlay

None.

4.8Interactionswithothermedicinalproductsandotherformofinteraction

Noneknown.

4.9Amountstobeadministeredandadministrationroute

Administration:Orallyviathedrinkingwater.

Dosage:7mgperkgofbodyweightperdayfor2consecutivedays,orally,thiscorrespondsto

28mloforalsolutionper100kgofbodyweightperdayor1.4mloftheproductperlitreof

drinkingwater,basedonawaterconsumptionof1litreper5kgbodyweight.

Thismedicinalproductshouldbeadministeredeithercontinuouslyover48hours,orforone8

hourperiodperdayfor2consecutivedays.

Thetotalweightofthetreatedanimalsandthedailywaterconsumptionmustbeaccurately

calculated.

Theconsumptionofwatermayvarydependinginparticularontheclinicalcondition,the

ambienttemperature,thelightingprogram,thedrinkingsystemused,theageandbreed.Ifthe

waterconsumptionismoreorlessthantheabovestandards,theconcentrationofthemedicinal

productinthedrinkingwatershouldbeadjustedaccordingly.

Useappropriateandproperlycalibrateddosingequipment.Medicatedwatershouldbetheonly

drinkingsource.

Themedicatedwaterisonlyusablefor24hoursandshouldbemadefreshlyeveryday.

Dilutionsmoreconcentratedthan3:1,000(3mlofproductto1litredrinkingwater)mayresult

inprecipitation.Predilutionandtheadministrationthroughadosingpump(proportioner)are

notrecommended.Usepreferablyabulktank.

4.10Overdose(symptoms,emergencyprocedures,antidotes)

Thefirstsignsofintolerancesuchasreducedwaterintakewereobservedbeyond5timesthe

recommendeddose.

4.11Withdrawalperiod

Meatandoffal:16days.

Eggs:Notauthorizedforuseinlayingbirdsproducingeggsforhumanconsumption.

5 PHARMACOLOGICALPROPERTIES

Pharmacotherapeuticgroup:antiprotozoals,triazines

ATCVetCode:QP51AJ01

5.1Pharmacodynamicproperties

Toltrazurilisatriazinonederivativeanticoccidial;itsmodeofactionisunknown.Itisactive

againstcoccidiaofthegenusEimeria.Itisactiveagainstallintracellulardevelopmentstages

includingschizogony(asexualmultiplication)andgametogony(sexualstage).

5.2.Pharmacokineticcharacteristics

Inpoultry,toltrazurilisabsorbedatarateofatleast50%.Theactivesubstanceisrapidly

metabolized.Themainmetaboliteisthetoltrazurilsulfone.

6.PHARMACEUTICALPARTICULARS

6.1Listofexcipients

Trolamine

Macrogol300

6.2Incompatibilities

Donotmixwithotherveterinarymedicinalproducts.

6.3Shelf-Life

Shelf-lifeoftheveterinarymedicinalproductaspackagedforsale:4years.

Shelf-lifeafterdilutionaccordingtodirections:24hours.

Shelf-lifeafterfirstopeningtheimmediatepackaging:3months.

6.4Specialprecautionsforstorage

Thisveterinarymedicinalproductdoesnotrequireanyspecialstorageconditions.

6.5Natureandcompositionoftheimmediatepackaging

1litrehigh-densitypolyethylenebottleswithhigh-densitypolyethylenescrewcapand

removablepolyethylenesealingdisk.

6.6Specialprecautionsforthedisposalofunusedveterinarymedicinalproductorwaste

materialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuchveterinary

medicinalproductsshouldbedisposedofinaccordancewithlocalrequirements.

7.MARKETINGAUTHORISATIONHOLDER

DopharmaResearchB.V.

Zalmweg24

4941VXRaamsdonksveerTheNetherlands

research@dopharma.com

8.MARKETINGAUTHORISATIONNUMBER(S)

9.DATEOFTHEFIRSTAUTHORISATION/RENEWALOFTHEAUTHORISATION

10.DATEOFREVISIONOFTHETEXT

PROHIBITIONOFSALE,SUPPLYAND/ORUSE

Underveterinaryprescription

27-11-2018

INNUENDO: A cross‐sectoral platform for the integration of genomics in the surveillance of food‐borne pathogens

INNUENDO: A cross‐sectoral platform for the integration of genomics in the surveillance of food‐borne pathogens

Published on: Mon, 26 Nov 2018 Abstract In response to the EFSA call New approaches in identifying and characterizing microbial and chemical hazards, the project INNUENDO (https://sites.google.com/site/theinnuendoproject/) aimed to design an analytical platform and standard procedures for the use of whole‐genome sequencing in surveillance and outbreak investigation of food‐borne pathogens. The project firstly attempted to identify existing flaws and needs, and then to provide applicable cross‐sectorial ...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Published on: Thu, 16 Aug 2018 00:00:00 +0200 4,15‐Diacetoxyscirpenol (DAS) is a mycotoxin primarily produced by Fusarium fungi and occurring predominantly in cereal grains. As requested by the European Commission, the EFSA Panel on Contaminants in the Food Chain (CONTAM) assessed the risk of DAS to human and animal health related to its presence in food and feed. Very limited information was available on toxicity and on toxicokinetics in experimental and farm animals. Due to the limitations in the avai...

Europe - EFSA - European Food Safety Authority Publications

25-6-2018

FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy

FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy

FDA approved Epidiolex (cannabidiol) oral solution, the first drug comprised of an active ingredient derived from marijuana, to treat two rare and severe forms of epilepsy.

FDA - U.S. Food and Drug Administration

24-5-2018

FDA Approves Semintra, the First FDA-approved Animal Drug for the Control of Systemic Hypertension in Cats

FDA Approves Semintra, the First FDA-approved Animal Drug for the Control of Systemic Hypertension in Cats

The FDA has approved Semintra (telmisartan oral solution), the first FDA-approved animal drug to control systemic hypertension in cats. Semintra is an oral solution administered either directly into the cat’s mouth or on top of a small amount of food.

FDA - U.S. Food and Drug Administration

There are no news related to this product.